Hybridoma Clone PVALD 434-3 4A4.2E12 or PVALD 434-3 4A4.6B10 Producing Monoclonal Antibody to Pfalciparum Aldolase or Monoclonal Antibody Purified from same Hybridoma

Case ID:
C10647
Disclosure Date:
2/16/2009
C10647: Monoclonal Antibody to Pfalciparum Aldolase (Hybridoma Clone PVALD 434-3 4A4.2E12 or PVALD 434-3 4A4.6B10)
Value Proposition:
• This technology has an application to address a major patient need.
• The ability to reliably diagnose malaria infections.
• The monoclonal antibodies specific to aldolase.
Technical Details:
Malaria is severe disease and caused by a parasite called Plasmodium. According to the World Health Organization, there were 247 million malaria cases and nearly a million deaths in 2006. Key intervention to control malaria is prompt and effective treatment with first step of good and reliable diagnostic testing. Hybridoma Clone PVALD 434-3 4A4.2E12 or PVALD 434-3 4A4.6B10 producing the monoclonal antibodies that are specific to an abundant malaria protein called aldolase, which recognizes all species of Plasmodium.
Looking for Partners:
The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.
Patent Information:
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum